Intech Biopharm Corporation (6461.TWO)
TWD 20.25
(-10.0%)
TWD 20.25
(-10.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -219.58 Million TWD | -0.05% |
| 2022 | -219.48 Million TWD | -11.46% |
| 2021 | -197.4 Million TWD | -32.51% |
| 2020 | -148.61 Million TWD | 0.0% |
| 2019 | -217.64 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -62 Million TWD | -36.72% |
| 2024 Q1 | -44.94 Million TWD | 34.19% |
| 2023 Q1 | -51.82 Million TWD | 25.77% |
| 2023 Q4 | -68.54 Million TWD | -22.04% |
| 2023 FY | - TWD | -0.05% |
| 2023 Q2 | -43.05 Million TWD | 16.92% |
| 2023 Q3 | -56.16 Million TWD | -30.47% |
| 2022 Q4 | -69.81 Million TWD | 0.0% |
| 2022 FY | - TWD | -11.46% |
| 2021 FY | - TWD | -32.51% |
| 2020 FY | - TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -374.84% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 155.788% |
| Level Biotechnology Inc. | 98.7 Million TWD | 322.468% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -390.813% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -204.493% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -770.229% |
| GlycoNex Incorporation | -126.82 Million TWD | -73.137% |
| VBI | -6.97 Million TWD | -3049.527% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | -52.813% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 1106.809% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -1138.774% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -111.924% |
| Visgeneer Inc. | 973 Thousand TWD | 22667.831% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 35.318% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 123.448% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 319.944% |
| Neith Corporation | -33.61 Million TWD | -553.332% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 77.844% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -12541.623% |
| Enimmune corporation | -228.96 Million TWD | 4.096% |
| TaiRx, Inc. | -208.64 Million TWD | -5.243% |
| CHO Pharma, Inc. | -277.73 Million TWD | 20.936% |
| EirGenix Inc. | -664.4 Million TWD | 66.95% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 397.122% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 417.581% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 79.505% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -94.141% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 730.303% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -252.232% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -734.924% |
| RBC Bioscience Corporation | 36.54 Million TWD | 700.829% |
| BiOptic Inc. | 65.03 Million TWD | 437.626% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 67.825% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -565.288% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -299.863% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 150.647% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -174.234% |
| NaviFUS Corp. | -55.79 Million TWD | -293.557% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -1222.961% |
| Sinew Pharma Inc. | -163.63 Million TWD | -34.195% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -257.049% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 214.128% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 3.129% |
| AP Biosciences Inc | -325.51 Million TWD | 32.542% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 78.979% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -512.579% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 853.811% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 67.432% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -388.499% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | -36.509% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 133.498% |
| TCI GENE Inc. | 25.98 Million TWD | 945.175% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -98.472% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 22.623% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -50.432% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 1685.451% |
| PharmaEngine, Inc. | 347.3 Million TWD | 163.225% |
| Savior Lifetec Corporation | 219.6 Million TWD | 199.991% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 227.495% |
| OBI Pharma, Inc. | -855.08 Million TWD | 74.32% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -137.228% |
| Acepodia, Inc. | -764.51 Million TWD | 71.278% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 52.273% |